Gene · 7068
Papers3,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Global Perspective on Metabolic Dysfunction-Associated Steatotic Liver Disease: From Molecular Mechanisms to Therapeutic Strategy Innovation. | Nutrients | 2026 | 41754196 | PubTator, text mining | PubMed |
| Metabolic Dysfunction-Associated Steatotic Liver Disease and Sarcopenia: Review of Literature. | J Clin Med | 2026 | 41753348 | PubTator, text mining | PubMed |
| New Treatment Options for MASLD Patients with Type 2 Diabetes. | Life (Basel) | 2026 | 41752891 | PubTator, text mining | PubMed |
| MASH in Type 2 Diabetes: Pathophysiology, Diagnosis, and Therapeutic Management-A Narrative Review. | Medicina (Kaunas) | 2026 | 41752724 | PubTator, text mining | PubMed |
| Acetate Metabolism in Thyroid Cancer Progression. | Int J Mol Sci | 2026 | 41752148 | PubTator, text mining | PubMed |
| Genetic Predisposition to MASLD: Potential for Therapeutic Management. | Int J Mol Sci | 2026 | 41752069 | PubTator, text mining | PubMed |
| NAFLD and Hypothyroidism: Deciphering Pivotal Genetic Variants, Cellular Expression Landscapes, and Spatial Architectures. | Int J Mol Sci | 2026 | 41751988 | PubTator, text mining | PubMed |
| Reconstructing Liver Fibrosis: 3D Human Models, Microbiome Interfaces, and Therapeutic Innovation. | Curr Issues Mol Biol | 2026 | 41751427 | PubTator, text mining | PubMed |
| Endobariatric Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review. | Biomedicines | 2026 | 41751244 | PubTator, text mining | PubMed |
| Nuclear Receptor-Targeted Therapies: Reprogramming Metabolism with TRβ, ERRα, and LXR Modulators. | Biomolecules | 2026 | 41750342 | PubTator, text mining | PubMed |
| Emerging Roles, Mechanisms, and Therapeutic Potential of Thyroid Hormones in Neurodegenerative Diseases: A Review. | Brain Sci | 2026 | 41750229 | PubTator, text mining | PubMed |
| Effect of Hormone Replacement Therapy on Liver and Cardiometabolic Outcomes in Peri-Menopausal MASLD. | Liver Int | 2026 | 41731345 | PubTator, text mining | PubMed |
| Single-cell analysis reveals the cellular and transcriptional heterogeneity of the normal pediatric thyroid. | Front Endocrinol (Lausanne) | 2026 | 41727685 | PubTator, text mining | PubMed |
| The Metabolic Dysfunction-Associated Steatotic Liver Disease-CKD Axis: Intersecting Pathways and Opportunities for Early Intervention. | Kidney Int Rep | 2026 | 41726005 | PubTator, text mining | PubMed |
| The Role of Race and Ethnicity in the Response to Metabolic Dysfunction-Associated Steatotic Liver Disease Treatment: A Review. | Endocr Pract | 2026 | 41720343 | PubTator, text mining | PubMed |
| Deciphering the potential molecular mechanism of resmetirom in idiosyncratic drug- induced autoimmune hepatitis using network toxicology and molecular docking. | In Silico Pharmacol | 2026 | 41717431 | PubTator, text mining | PubMed |
| The autophagy-senescence axis as a threshold model of aging and therapeutic targeting. | Redox Biol | 2026 | 41690118 | PubTator, text mining | PubMed |
| Determining the Impacts of an Aquatic Copper Exposure to Ambystoma Gracile (Northwestern Salamander). | Arch Environ Contam Toxicol | 2026 | 41670719 | PubTator, text mining | PubMed |
| Applications of Artificial Intelligence and Smart Devices in Metabolic Dysfunction-associated Steatotic Liver Disease. | J Clin Transl Hepatol | 2026 | 41659991 | PubTator, text mining | PubMed |
| Identification of a novel THRB mutation causing thyroid hormone resistance syndrome. | Arch Endocrinol Metab | 2026 | 41649337 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7068/papers?page=5